Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV002269238 | SCV002552526 | uncertain significance | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003096091 | SCV003521781 | uncertain significance | Familial adenomatous polyposis 2 | 2023-06-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1697954). This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 95 of the MUTYH protein (p.Ala95Asp). |
Revvity Omics, |
RCV003096091 | SCV003817135 | uncertain significance | Familial adenomatous polyposis 2 | 2022-04-01 | criteria provided, single submitter | clinical testing |